Astera Labs (NASDAQ:ALAB) Trading Down 1.9% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price traded down 1.9% on Friday . The company traded as low as $277.30 and last traded at $284.97. Approximately 2,999,423 shares were traded during mid-day trading, a decline of 45% from the average session volume of 5,451,113 shares. The stock had previously closed at $290.52.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Barclays raised their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday. Finally, JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Trading Down 1.9%

The stock has a market capitalization of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84. The stock’s 50 day simple moving average is $352.70 and its 200 day simple moving average is $244.92.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently made changes to their positions in the company. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $25,000. Archer Investment Corp bought a new position in Astera Labs during the second quarter worth $30,000. Transamerica Financial Advisors LLC bought a new position in Astera Labs during the second quarter worth $35,000. Continuum Advisory LLC acquired a new position in Astera Labs in the second quarter worth $37,000. Finally, Johnson Financial Group Inc. acquired a new position in Astera Labs in the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.